27 Mar 2025
Selpercatinib – Can you Help?
SMC Patient Submission – selpercatinib
AMEND is preparing a patient group submission for the Scottish Medicine’s Consortium for the assessment of selpercatinib for use in metastatic MTC with the hope of getting it approved. To help with this, we would be grateful for your input regarding what kind of impact treating a patient with selpercatinib may have on the patient’s family or carers.
If anyone (carer or patient) would like to send a comment on this to include in this submission, please send it to AMEND CEO, Jo Grey via email. You or your loved one don’t have to be taking selpercatinib, nor do you have to be Scottish or from the UK.
.